Outcomes with durvalumab by tumour PD-L1 expression in unresectable, stage III non-small-cell lung cancer in the PACIFIC trial
Luis Paz‐Ares, Alexander I. Spira, David Raben, David Planchard, Byoung Chul Cho, Mustafa Özgüroğlu, Davey B. Daniel, Augusto Villegas, David Vicente, Rina Hui, S. Murakami, David R. Spigel, Suresh Senan, Corey J. Langer, Bradford A. Perez, A-M. Boothman, Helen Broadhurst, Catherine Wadsworth, P. Dennis, Scott Antonia, Corinne Faivre‐Finn
Topics & Concepts
DurvalumabMedicineOncologyStage (stratigraphy)Internal medicineLung cancerCancerImmunotherapyNivolumabPaleontologyBiologyCancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsRadiomics and Machine Learning in Medical Imaging